AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq ...

The market is expected to take a cue from the budget for further direction, while volatility may remain on the higher side.

The Fed's preferred inflation gauge, the personal consumption and expenditures index, rose 0.3% from November and 2.6% on an annual basis.